rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    VNDA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Retail investor enthusiasm for Anthropic IPO to rival SpaceX debut

      Anthropic is gearing up for a blockbuster initial public offering this week, and excitement among retail investors looks to be off the charts.

      12h agoCNBCSPCXVNDA
      Nvidia Sees Record Open Retail Buy After CEO Ousted, Vanda Says
      Nov 13BloombergVNDA
      Anthropic IPO could draw record retail buyers, Vanda Research says
      Nov 11Yahoo FinanceVNDA
      Anthropic IPO could draw record retail buying, Vanda Research says By Reuters
      Nov 11Investing.comVNDA
      Anthropic IPO could draw record retail buying, Vanda Research says
      Nov 11ReutersVNDA
      Vanda Pharmaceuticals at Stifel 2026 Healthcare Conference: growth before loe
      Nov 11Investing.comVNDASF
      Retail investors flee single stocks at fastest pace since COVID crash - Vanda (SPY:NYSEARCA)

      Retail investors dumped individual stocks at a pandemic-era pace as institutions pulled back.

      Nov 5Seeking AlphaVNDA
      Vanda Pharmaceuticals Inc (VNDA) (Q3 2026) Earnings Call Highlights: Revenue Jumps 24% as ...
      Nov 1Yahoo FinanceVNDA
      Why is Vanda Pharmaceuticals stock rallying today?
      Oct 29Investing.comVNDA
      Vanda Pharmaceuticals Inc. Q3 2026 Earnings Call Summary
      Oct 29Yahoo FinanceVNDA
      Vanda Pharmaceuticals Q3 Earnings Call Highlights
      Oct 29Yahoo FinanceVNDA
      Vanda Pharma Q3 2026 Earnings Call Transcript
      Oct 28BenzingaVNDA
      Earnings call transcript: Vanda beats Q3 2026 estimates as shares rise after hours
      Oct 28Investing.comVNDA
      Vanda earnings beat by $0.31, revenue topped estimates
      Oct 28Investing.comVNDA
      Vanda Pharmaceuticals (VNDA) Reports Q3 Loss, Tops Revenue Estimates
      Oct 28Yahoo FinanceVNDA
      Vanda: Q3 Earnings Snapshot
      Oct 28Yahoo FinanceVNDA
      Vanda Pharmaceuticals Targets Major GLP-1 Market Challenge with Positive Trial Outcomes
      Oct 27BenzingaVNDA
      Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026
      Oct 21Yahoo FinanceVNDA
      Vanda Pharmaceuticals: Cash Is Running Out Faster Than The Launches (NASDAQ:VNDA)
      Oct 15Seeking AlphaVNDA
      Vanda Pharmaceuticals Says Experimental Anxiety Treatment Misses Primary Endpoint
      Oct 15BenzingaVNDA
      Vanda says anxiety drug failed main goal of late-stage study, puts program on hold
      Oct 14Yahoo FinanceVNDA
      Vanda Pharmaceuticals' Late-Stage Study of VQW-765 to Treat Acute Anxiety Fails to Meet Primary Endpoint
      Oct 14Yahoo FinanceVNDA
      Vanda Pharmaceuticals stock falls after anxiety drug trial fails
      Oct 14Investing.comVNDA
      Vanda’s phase III trial for social anxiety drug fails
      Oct 14Investing.comVNDA
      Vanda’s Tasimelteon Study Completion: What Sleep Trial Progress Means for VNDA Investors

      Tipranks Press Release.

      Oct 10The Globe and MailVNDA
      Wainwright reiterates Buy on Vanda stock after sleep disorder trial
      Oct 5Investing.comVNDA
      Vanda Pharmaceuticals Announces Presentation at 2026 EADV Annual Meeting
      Oct 2MorningstarVNDA
      Vanda: 'Hold' On Hetlioz Trial Win, But Several Risk Factors Remain For It (NASDAQ:VNDA)
      Oct 1Seeking AlphaVNDA
      Vanda Eyes First FDA-Approved Delayed Sleep-Wake Disorder Drug - Vanda Pharmaceuticals (NASDAQ:VNDA)

      Vanda's Phase 3 trial of HETLIOZ for DSWPD met its primary endpoint, advancing sleep onset by 42.5 minutes. sNDA submission planned.

      Sep 30BenzingaVNDA
      Why is Vanda Pharmaceuticals stock surging today?
      Sep 29Investing.comVNDA
      Yields bite, but 'smart money' still gorging on AI - Vanda (TLT:NASDAQ)
      Sep 25Seeking AlphaVNDA
      Oppenheimer initiates Vanda Pharmaceuticals stock with outperform rating
      Sep 23Investing.comVNDA
      Vanda Pharmaceuticals at H.C. Wainwright conference: pipeline broadens
      Sep 15Investing.comVNDA
      Vanda Pharmaceuticals at Cantor conference: psychiatry push takes center stage
      Sep 11Investing.comVNDA
      Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences
      Sep 2Yahoo FinanceVNDA
      Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission
      Aug 24MorningstarVNDA
      Vanda gets EU orphan designation for psoriasis drug imsidolimab
      Aug 24Investing.comVNDA
      NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C.
      Aug 22MorningstarVNDA

      This is the newest page. Registered accounts read further back.